Literature DB >> 26694758

Robustness of ordinary least squares in randomized clinical trials.

David R Judkins1, Kristin E Porter2.   

Abstract

There has been a series of occasional papers in this journal about semiparametric methods for robust covariate control in the analysis of clinical trials. These methods are fairly easy to apply on currently available computers, but standard software packages do not yet support these methods with easy option selections. Moreover, these methods can be difficult to explain to practitioners who have only a basic statistical education. There is also a somewhat neglected history demonstrating that ordinary least squares (OLS) is very robust to the types of outcome distribution features that have motivated the newer methods for robust covariate control. We review these two strands of literature and report on some new simulations that demonstrate the robustness of OLS to more extreme normality violations than previously explored. The new simulations involve two strongly leptokurtic outcomes: near-zero binary outcomes and zero-inflated gamma outcomes. Potential examples of such outcomes include, respectively, 5-year survival rates for stage IV cancer and healthcare claim amounts for rare conditions. We find that traditional OLS methods work very well down to very small sample sizes for such outcomes. Under some circumstances, OLS with robust standard errors work well with even smaller sample sizes. Given this literature review and our new simulations, we think that most researchers may comfortably continue using standard OLS software, preferably with the robust standard errors.
Copyright © 2015 John Wiley & Sons, Ltd.

Entities:  

Keywords:  OLS; nonparametric ANCOVA; semiparametric ANOVA

Mesh:

Year:  2015        PMID: 26694758     DOI: 10.1002/sim.6839

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  5 in total

1.  Arginine-Nitric Oxide Metabolites and Cardiac Dysfunction in Patients With Breast Cancer.

Authors:  Brian S Finkelman; Mary Putt; Teresa Wang; Le Wang; Hari Narayan; Susan Domchek; Angela DeMichele; Kevin Fox; Jennifer Matro; Payal Shah; Amy Clark; Angela Bradbury; Vivek Narayan; Joseph R Carver; W H Wilson Tang; Bonnie Ky
Journal:  J Am Coll Cardiol       Date:  2017-07-11       Impact factor: 24.094

2.  Types of Erythropoietin-Stimulating Agents and Mortality among Patients Undergoing Hemodialysis.

Authors:  Yusuke Sakaguchi; Takayuki Hamano; Atsushi Wada; Ikuto Masakane
Journal:  J Am Soc Nephrol       Date:  2019-04-23       Impact factor: 10.121

3.  What Interventions Work Best for Families Who Experience Homelessness? Impact Estimates from the Family Options Study.

Authors:  Daniel Gubits; Marybeth Shinn; Michelle Wood; Scott R Brown; Samuel R Dastrup; Stephen H Bell
Journal:  J Policy Anal Manage       Date:  2018

4.  Trends, relationships and case attribution of antibiotic resistance between children and environmental sources in rural India.

Authors:  Joseph Mitchell; Manju Purohit; Chris P Jewell; Jonathan M Read; Gaetano Marrone; Vishal Diwan; Cecilia Stålsby Lundborg
Journal:  Sci Rep       Date:  2021-11-19       Impact factor: 4.379

5.  Optimal Allocation of Interviews to Baseline and Endline Surveys in Place-Based Randomized Trials and Quasi-Experiments.

Authors:  Donald P Green; Winston Lin; Claudia Gerber
Journal:  Eval Rev       Date:  2018-10-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.